World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
50
Citations
9388
World Ranking
14341
National Ranking
3695

Ann E. Weber publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Ann E. Weber sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 144 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Ann E. Weber D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ann E. Weber sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 50 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2019 - Fellow of the American Chemical Society
  • 2017 - Perkin Medal, Society of Chemical Industry, American Section

Overview

Ann E. Weber is affiliated with MSD in the United States. Their research spans several fields predominantly within medicine, biochemistry, genetics, and molecular biology. Key subfields include endocrinology, diabetes and metabolism, cellular and molecular neuroscience, molecular medicine, infectious diseases, and epidemiology.

Weber has contributed to topics such as:

  • Diabetes treatment and management
  • Neuropeptides and animal physiology
  • Antibiotic resistance in bacteria
  • Tuberculosis research and epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Receptor mechanisms and signaling
  • Sex and gender in healthcare

Their recent publications include:

  • "Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates," 2022, Journal of Medicinal Chemistry
  • "Applying a gender lens to global health and well-being: Framing a Journal of Global Health special collection," 2020, Journal of Global Health
  • "Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders," 2025, Journal of Medicinal Chemistry
  • "Dipeptidyl Peptidase 4 Inhibitors," 2021, Burger's Medicinal Chemistry and Drug Discovery
  • "A digital app-supported general practitioner-led weight loss program improves food literacy and intake in adults in rural Germany: Secondary outcomes of the HAPpEN pragmatic trial," 2025, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors working alongside Weber include:

  • Mihirbaran Mandal
  • Li Xiao
  • Weidong Pan
  • Giovanna Scapin
  • Guoqing Li

Common venues for Weber's work encompass:

  • Journal of Medicinal Chemistry
  • Journal of Global Health
  • Burger's Medicinal Chemistry and Drug Discovery
  • bioRxiv (Cold Spring Harbor Laboratory)

Weber has been recognized with awards including the Fellow of the American Chemical Society in 2019 and the Perkin Medal from the Society of Chemical Industry, American Section, in 2017.

Best Publications

  • (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

    Dooseop Kim;Liping Wang;Maria Beconi;George J. Eiermann

  • Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes: Potential Importance of Selectivity Over Dipeptidyl Peptidases 8 and 9

    George R. Lankas;Barbara Leiting;Ranabir Sinha Roy;George J. Eiermann

  • Dipeptidyl peptidase IV inhibitors for the treatment of diabetes.

    Ann E Weber

  • Asymmetric glycine enolate aldol reactions: synthesis of cyclosporin's unusual amino acid, MeBmt

    David A. Evans;Ann E. Weber

  • Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

    Tesfaye Biftu;Gui-Bai Liang;Xiaoxia Qian;Ann E. Weber

  • Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

    Linda L Brockunier;Emma R Parmee;Hyun O Ok;Mari R Candelore

  • Synthesis of the cyclic hexapeptide echinocandin D. New approaches to the asymmetric synthesis of .beta.-hydroxy .alpha.-amino acids

    David A. Evans;Ann E. Weber

  • Discovery of JANUVIA (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

    Nancy A Thornberry;Ann E Weber

  • Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes.

    Tesfaye Biftu;Ranabir Sinha-Roy;Ping Chen;Xiaoxia Qian

  • Asymmetric synthesis of anti-β-hydroxy-α-amino acids

    David A. Evans;Eric B. Sjogren;Ann E. Weber;Robin E. Conn

  • Potent and selective human beta(3)-adrenergic receptor antagonists.

    Mari Rios Candelore;Liping Deng;Laurie Tota;Xiao-Ming Guan

  • (2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]- pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

    Edmondson Sd;Mastracchio A;Mathvink Rj;He J

  • Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

    Tesfaye Biftu;Jason Cox;Danqing Feng;Anthony Mastracchio

  • Substituted piperazines as novel dipeptidyl peptidase IV inhibitors

    Linda L. Brockunier;Jiafang He;Lawrence F. Colwell;Bahanu Habulihaz

  • Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

    Wallace T. Ashton;Charles G. Caldwell;Hyun O. Ok;Emma R. Parmee

  • Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors.

    Jinyou Xu;Hyun O. Ok;Edward J. Gonzalez;Lawrence F. Colwell

  • 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

    Wallace T. Ashton;Charles G. Caldwell;Robert J. Mathvink;Hyun O. Ok

  • Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors

    Scott D. Edmondson;Lan Wei;Jinyou Xu;Jackie Shang

  • A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice.

    Joel P. Berger;Ranabir SinhaRoy;Alessandro Pocai;Theresa M. Kelly

  • Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

    Scott D. Edmondson;Cheng Zhu;Nam Fung Kar;Jerry Di Salvo

  • Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors.

    Charles G. Caldwell;Ping Chen;Jiafang He;Emma R. Parmee

  • Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

    Joseph L. Duffy;Robert J. Mathvink;Ann E. Weber;Jinyou Xu

  • OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE -g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY

    Tesfaye Biftu;Danqing Dennis Feng;Michael H Fisher;Chan-Hwa Kuo

Frequent Co-Authors

Michael H. Fisher
Michael H. Fisher MSD (United States)
Nancy A. Thornberry
Nancy A. Thornberry MSD (United States)
Malcolm Maccoss
Malcolm Maccoss MSD (United States)
Giovanna Scapin
Giovanna Scapin MSD (United States)
Matthew J. Wyvratt
Matthew J. Wyvratt Medicines for Malaria Venture
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Catherine D. Strader
Catherine D. Strader MSD (United States)
Arthur A. Patchett
Arthur A. Patchett MSD (United States)
William J. Greenlee
William J. Greenlee MSD (United States)
David A. Evans
David A. Evans Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond traditional Chemistry paths, related fields like forensic science and criminal justice offer promising opportunities. Pursuing an online master's in forensic psychology can blend scientific knowledge with legal and psychological principles, opening doors to specialized careers.

Understanding the financial aspects is crucial. The criminal justice degree cost varies widely depending on the institution and program, but many accredited programs offer competitive tuition rates and financial aid options to help manage expenses.

Starting with an accredited online criminal justice associate degree allows students to gain foundational knowledge while maintaining flexibility, which can be ideal for working professionals or those transitioning from other fields.

Career prospects in these areas are promising, especially for those with a strong scientific background. Forensic science positions often offer competitive forensic science degree salary packages, reflecting the technical expertise required.

Best Scientists Citing Ann E. Weber

Trending Scientists

Recently Published Articles